Revenue
2019
2020
2021
2022
2023
2024
2025
Maxcyte, Inc. (MXCT)
Price$1.28Cached quote
Net income
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Revenue | $21.0M | $22.2M | $19.5M | $28.7M | $21.6M | $15.5M | $13.3M |
| Gross profit | $26.8M | $31.5M | $36.5M | $39.2M | $30.2M | $23.4M | $19.1M |
| Gross margin | 127.90% | 141.92% | 187.44% | 136.23% | 140.22% | 151.45% | 144.23% |
| Research & development | $20.8M | $22.2M | $23.8M | $19.5M | $15.4M | $17.7M | $17.6M |
| Operating expenses | $78.7M | $82.7M | $84.8M | $66.5M | $48.4M | $34.5M | $31.5M |
| Operating income | −$51.9M | −$51.2M | −$48.3M | −$27.4M | −$18.2M | −$11.1M | −$12.4M |
| Operating margin | −247.64% | −230.46% | −247.73% | −95.18% | −84.32% | −71.56% | −93.68% |
| EBITDA | −$47.6M | −$46.9M | −$44.1M | −$24.7M | −$16.8M | −$10.0M | −$11.8M |
| EBITDA margin | −226.93% | −211.04% | −226.33% | −85.79% | −77.72% | −64.78% | −89.06% |
| Net income | −$44.6M | −$41.1M | −$37.9M | −$23.6M | −$19.1M | −$11.8M | −$12.9M |
| Net profit margin | −212.96% | −184.81% | −194.51% | −81.99% | −88.46% | −76.47% | −97.27% |
| Basic EPSper basic share | -$0.42 | -$0.39 | -$0.37 | -$0.23 | -$0.21 | -$0.17 | -$0.23 |
| Diluted EPSper diluted share | -$0.42 | -$0.39 | -$0.37 | -$0.23 | -$0.21 | -$0.17 | -$0.23 |
Owners
Reported shareholders
7.73%of listed shares
Capricorn Fund Managers Ltd8.2M shares · Jun 30, 2026
View holders
| Holder | % owned |
|---|---|
Capricorn Fund Managers Ltd | 7.73%8.2M shares |
Vitruvian Partners LLP | 4.75%5.04M shares |
VANGUARD CAPITAL MANAGEMENT LLC | 3.80%4.03M shares |
MORGAN STANLEY | 3.48%3.69M shares |
Mudita Advisors LLP | 3.18%3.37M shares |
BlackRock, Inc. | 2.88%3.06M shares |
Brooklands Fund Management Ltd | 2.68%2.85M shares |
BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 2.61%2.77M shares |
CADIAN CAPITAL MANAGEMENT, LP | 2.07%2.2M shares |
Peapod Lane Capital LLC | 2.00%2.13M shares |
RENAISSANCE TECHNOLOGIES LLC | 1.80%1.91M shares |
AQR CAPITAL MANAGEMENT LLC | 1.77%1.88M shares |
JANE STREET GROUP, LLC | 1.47%1.56M shares |
TWO SIGMA INVESTMENTS, LP | 1.38%1.46M shares |
GEODE CAPITAL MANAGEMENT, LLC | 1.25%1.33M shares |
RBF Capital, LLC | 1.25%1.32M shares |
GOLDMAN SACHS GROUP INC | 1.17%1.24M shares |
MILLENNIUM MANAGEMENT LLC | 1.14%1.2M shares |
NANO CAP NEW MILLENNIUM GROWTH FUND L P | 1.13%1.2M shares |
MARSHALL WACE, LLP | 0.96%1.01M shares |
Percentages use 106.13M shares of this listed class outstanding on Jun 30, 2026.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Mar 17, 2026Form 4 | Swirsky Douglas JCHIEF FINANCIAL OFFICER | SellCommon Stock | 10.1K | $0.82 | $8.3K | 151.7K |
| Aug 13, 2025Form 4 | Swirsky Douglas JCHIEF FINANCIAL OFFICER | BuyCommon Stock | 50.0K | $1.29 | $64.5K | 161.8K |
| Aug 13, 2025Form 4 | Masoud MaherPresident and CEO | BuyCommon Stock | 75.0K | $1.37 | $102.8K | 175.0K |
| Aug 13, 2025Form 4 | Erck Stanley CDirector | BuyCommon Stock | 100.0K | $1.37 | $137.0K | 398.3K |
| Aug 13, 2025Form 4 | DOUGLAS RICHARDDirector | BuyCommon Stock | 80.0K | $1.39 | $111.2K | 230.6K |